About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Ensysce Biosciences and Quotient Sciences to develop opioid to prevent abuse and overdose

Anti-cancer drug created from reprogrammed yeast

Compound found in trees has potential to kill drug-resistant bacteria

Researchers identify possible target for type of sporadic ALS

United BioPharma gets FDA approval for phase 2 HIV drug trial

Emactuzumab designated as an orphan medicinal product for TGCT in Europe

ADVERTISEMENT

Laverock Therapeutics created to develop next generation of programmable cell therapies

Research shows TikoMed’s ILB has the potential to treat neurodegenerative diseases including ALS

Vilya emerges to target disease biology

Grid Biosciences signs agreement with NIH for Epstein-Barr virus vaccine

PharmAla Biotech files patent applications for MDMA analogs

Malaysian Genomics and Ajlan to explore MENA biopharma opportunities

ADVERTISEMENT